Completed OBSERVATIONAL NCT03478254

Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-1). (AVADI-1)

Adherence to Guidelines for Influenza, Pneumococcal and Hepatitis B Vaccination in Adult Patients With Type 1 Diabetes Mellitus (AVADI-1).

Sponsor: Castilla-La Mancha Health Service

Conditions Type 1 Diabetes Mellitus

Interventions Hepatitis B Virus (HBV) vaccination Influenza vaccination Pneumococcal vaccination

Updated 9 times since 2018 Last updated: Dec 16, 2020 Started: Dec 1, 2017 Primary completion: Dec 1, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Type 1 Diabetes Mellitus and is currently completed. Castilla-La Mancha Health Service leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed
Dec 2022 — Jan 2023 [monthly]

Completed
Feb 2021 — Dec 2022 [monthly]

Completed

▶ Show 4 earlier versions

Jan 2021 — Feb 2021 [monthly]

Completed
Feb 2019 — Jan 2021 [monthly]

Completed

Status: Recruiting → Completed
Jun 2018 — Feb 2019 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

First recorded

Dec 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Castilla-La Mancha Health Service
Jesús Moreno Fernández
University of Castilla-La Mancha

Data source: Castilla-La Mancha Health Service

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ciudad Real, Spain